menu
    • menu

    Company profile for CalciMedica

    NEW Drugs in Dev: 8
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Together we can improve the quality of life

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    CalciMedica was founded in December 2006 to pursue the discovery and development of novel calcium release-activated calcium (CRAC) channel inhibitors for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The Company acquired exclusive rights to both STIM1 and Orai1, the major protein components of the CRAC channel, for its research program.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CalciMedicaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    La Jolla, California
    Telephone
    Telephone
    858-952-5500
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://calcimedica.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    34th NZW-Hamburg

    Not Confirmed

    envelop Contact Supplier

    34th NZW-Hamburg

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    CalciMedica Discontinues Phase 2 KOURAGE Trial in AKI
    CalciMedica Discontinues Phase 2 KOURAGE Trial in AKI

    28 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/calcimedica-announces-discontinuation-of-phase-2-kourage-trial-in-aki-following-independent-data-monitoring-committee-recommendation-302671925.html

    PR NEWSWIRE
    28 Jan 2026
    Share Share
    Calcimedica Publishes Preclinical Data On CRAC Channel Inhibitor
    Calcimedica Publishes Preclinical Data On CRAC Channel Inhibitor

    12 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/calcimedica-announces-publication-in-jci-insight-of-preclinical-data-supporting-crac-channel-inhibitor-as-a-potential-therapy-for-pulmonary-arterial-hypertension-302612201.html

    PR NEWSWIRE
    12 Nov 2025
    Share Share
    Calcimedica Reveals Q3 2025 Financials & Clinical Progress
    Calcimedica Reveals Q3 2025 Financials & Clinical Progress

    12 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/calcimedica-reports-third-quarter-2025-financial-results-and-provides-clinical--corporate-updates-302612229.html

    PR NEWSWIRE
    12 Nov 2025
    Share Share
    Calcimedica, Telperian Partner To Integrate AI In Auxora Trials
    Calcimedica, Telperian Partner To Integrate AI In Auxora Trials

    14 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/calcimedica-and-telperian-announce-collaboration-to-integrate-innovative-artificial-intelligence-engine-to-analysis-of-clinical-trials-of-auxora-302582264.html

    PR NEWSWIRE
    14 Oct 2025
    Share Share
    CalciMedica to Attend H.C. Wainwright Global Conference
    CalciMedica to Attend H.C. Wainwright Global Conference

    02 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/calcimedica-to-participate-in-the-hc-wainwright-27th-annual-global-investment-conference-302542326.html

    PR NEWSWIRE
    02 Sep 2025
    Share Share
    CalciMedica's Q2 2025 Financial Results and Clinical Updates
    CalciMedica's Q2 2025 Financial Results and Clinical Updates

    12 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/calcimedica-reports-second-quarter-2025-financial-results-and-provides-clinical--corporate-updates-302526849.html

    PR NEWSWIRE
    12 Aug 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search